Search

Rita J Desai

Examiner (ID: 14900, Phone: (571)272-0684 , Office: P/1625 )

Most Active Art Unit
1625
Art Unit(s)
1612, 1625
Total Applications
2152
Issued Applications
1290
Pending Applications
146
Abandoned Applications
716

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 13661215 [patent_doc_number] => 10160759 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-12-25 [patent_title] => Hydroxyethyl sulfonate of cyclin-dependent protein kinase inhibitor, crystalline form thereof and preparation method therefor [patent_app_type] => utility [patent_app_number] => 15/952234 [patent_app_country] => US [patent_app_date] => 2018-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3352 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15952234 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/952234
Hydroxyethyl sulfonate of cyclin-dependent protein kinase inhibitor, crystalline form thereof and preparation method therefor Apr 12, 2018 Issued
Array ( [id] => 17938366 [patent_doc_number] => 11472807 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-10-18 [patent_title] => Purine derivatives for use as medicament and for use in treating neurodegenerative or neuro-inflammatory disorders [patent_app_type] => utility [patent_app_number] => 16/604330 [patent_app_country] => US [patent_app_date] => 2018-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 37 [patent_no_of_words] => 17380 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 176 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16604330 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/604330
Purine derivatives for use as medicament and for use in treating neurodegenerative or neuro-inflammatory disorders Apr 8, 2018 Issued
Array ( [id] => 17192080 [patent_doc_number] => 11160809 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-11-02 [patent_title] => NK1-antagonist combination and method for treating synucleinopathies [patent_app_type] => utility [patent_app_number] => 16/604468 [patent_app_country] => US [patent_app_date] => 2018-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18280 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16604468 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/604468
NK1-antagonist combination and method for treating synucleinopathies Apr 8, 2018 Issued
Array ( [id] => 15524699 [patent_doc_number] => 20200054655 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-20 [patent_title] => COMBINATION THERAPIES USING CASPASE-1 DEPENDENT ANTICANCER AGENTS AND PGE2 ANTAGONISTS [patent_app_type] => utility [patent_app_number] => 16/603502 [patent_app_country] => US [patent_app_date] => 2018-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46450 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16603502 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/603502
Combination therapies using caspase-1 dependent anticancer agents and PGE2 antagonists Apr 5, 2018 Issued
Array ( [id] => 15008363 [patent_doc_number] => 10450297 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-10-22 [patent_title] => Sulfonyl amide derivatives for the treatment of abnormal cell growth [patent_app_type] => utility [patent_app_number] => 15/946117 [patent_app_country] => US [patent_app_date] => 2018-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40348 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15946117 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/946117
Sulfonyl amide derivatives for the treatment of abnormal cell growth Apr 4, 2018 Issued
Array ( [id] => 13478911 [patent_doc_number] => 20180290998 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-11 [patent_title] => METALLOENZYME INHIBITOR COMPOUNDS AS FUNGICIDES [patent_app_type] => utility [patent_app_number] => 15/945334 [patent_app_country] => US [patent_app_date] => 2018-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18485 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15945334 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/945334
METALLOENZYME INHIBITOR COMPOUNDS AS FUNGICIDES Apr 3, 2018 Abandoned
Array ( [id] => 15451121 [patent_doc_number] => 20200038384 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-06 [patent_title] => DIHYDROTETRABENAZINE FOR THE TREATMENT OF ANXIETY AND PSYCHOSES [patent_app_type] => utility [patent_app_number] => 16/498697 [patent_app_country] => US [patent_app_date] => 2018-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7412 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16498697 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/498697
Dihydrotetrabenazine for the treatment of anxiety and psychoses Mar 28, 2018 Issued
Array ( [id] => 16421881 [patent_doc_number] => 20200347079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-05 [patent_title] => NOVEL PTEFB INHIBITING MACROCYCLIC COMPOUNDS [patent_app_type] => utility [patent_app_number] => 16/497578 [patent_app_country] => US [patent_app_date] => 2018-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40699 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16497578 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/497578
PTEFb inhibiting macrocyclic compounds Mar 21, 2018 Issued
Array ( [id] => 13519393 [patent_doc_number] => 20180311239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-01 [patent_title] => HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF SUMO ACTIVATING ENZYME [patent_app_type] => utility [patent_app_number] => 15/923015 [patent_app_country] => US [patent_app_date] => 2018-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 180704 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15923015 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/923015
Heteroaryl compounds useful as inhibitors of sumo activating enzyme Mar 15, 2018 Issued
Array ( [id] => 16892023 [patent_doc_number] => 11033549 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-15 [patent_title] => Use of heterocyclic compounds in the treatment of pigmented skin [patent_app_type] => utility [patent_app_number] => 16/493317 [patent_app_country] => US [patent_app_date] => 2018-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12253 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 160 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16493317 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/493317
Use of heterocyclic compounds in the treatment of pigmented skin Mar 13, 2018 Issued
Array ( [id] => 13413103 [patent_doc_number] => 20180258094 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-13 [patent_title] => GLUCURONIDE PRODRUGS OF TOFACITINIB [patent_app_type] => utility [patent_app_number] => 15/914189 [patent_app_country] => US [patent_app_date] => 2018-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20598 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -50 [patent_words_short_claim] => 286 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15914189 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/914189
Glucuronide prodrugs of tofacitinib Mar 6, 2018 Issued
Array ( [id] => 17096868 [patent_doc_number] => 20210284659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-16 [patent_title] => INHIBITORS OF BETA SECRETASE [patent_app_type] => utility [patent_app_number] => 16/489856 [patent_app_country] => US [patent_app_date] => 2018-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13883 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16489856 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/489856
INHIBITORS OF BETA SECRETASE Mar 5, 2018 Abandoned
Array ( [id] => 17185175 [patent_doc_number] => 20210332060 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-28 [patent_title] => A Simple Process for Preparing Avibactam [patent_app_type] => utility [patent_app_number] => 16/345791 [patent_app_country] => US [patent_app_date] => 2018-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6704 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 322 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16345791 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/345791
Simple process for preparing avibactam Mar 5, 2018 Issued
Array ( [id] => 15323983 [patent_doc_number] => 20200002321 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-02 [patent_title] => OXAZOLIDINONES AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR TREATING BACTERIAL INFECTIONS, INCLUDING INFECTION OF MYCOBACTERIUM TUBERCULOSIS [patent_app_type] => utility [patent_app_number] => 16/489234 [patent_app_country] => US [patent_app_date] => 2018-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11150 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 232 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16489234 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/489234
Oxazolidinones and pharmaceutical compositions thereof for treating bacterial infections, including infection of Feb 25, 2018 Issued
Array ( [id] => 15556595 [patent_doc_number] => 20200062709 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-27 [patent_title] => METHOD OF PRODUCING PENTAFLUOROSULFANYL AROMATIC COMPOUND [patent_app_type] => utility [patent_app_number] => 16/489275 [patent_app_country] => US [patent_app_date] => 2018-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3146 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16489275 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/489275
Method of producing pentafluorosulfanyl aromatic compound Feb 25, 2018 Issued
Array ( [id] => 13774613 [patent_doc_number] => 20190000845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-03 [patent_title] => PHENYLOXADIAZOLE DERIVATIVES AS PGDS INHIBITORS [patent_app_type] => utility [patent_app_number] => 15/903337 [patent_app_country] => US [patent_app_date] => 2018-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10725 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15903337 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/903337
PHENYLOXADIAZOLE DERIVATIVES AS PGDS INHIBITORS Feb 22, 2018 Abandoned
Array ( [id] => 13386197 [patent_doc_number] => 20180244640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-30 [patent_title] => Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use [patent_app_type] => utility [patent_app_number] => 15/902802 [patent_app_country] => US [patent_app_date] => 2018-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 67138 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15902802 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/902802
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use Feb 21, 2018 Issued
Array ( [id] => 12862090 [patent_doc_number] => 20180179204 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-28 [patent_title] => INHIBITORS OF LYSINE SPECIFIC DEMETHYLASE-1 [patent_app_type] => utility [patent_app_number] => 15/900737 [patent_app_country] => US [patent_app_date] => 2018-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40749 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -47 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15900737 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/900737
Inhibitors of lysine specific demethylase-1 Feb 19, 2018 Issued
Array ( [id] => 15324015 [patent_doc_number] => 20200002337 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-02 [patent_title] => DIHYDROPYRIDOPHTHALAZINONE COMPOUNDS AS INHIBITORS OF POLY (ADP-RIBOSE) POLYMERASE (PARP) FOR TREATMENT OF DISEASES AND METHOD OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/487919 [patent_app_country] => US [patent_app_date] => 2018-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7880 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16487919 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/487919
DIHYDROPYRIDOPHTHALAZINONE COMPOUNDS AS INHIBITORS OF POLY (ADP-RIBOSE) POLYMERASE (PARP) FOR TREATMENT OF DISEASES AND METHOD OF USE THEREOF Feb 8, 2018 Abandoned
Array ( [id] => 16051289 [patent_doc_number] => 20200187499 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-18 [patent_title] => SUBSTITUTED BENZYL-4-AMINOPICOLINIC ESTERS AND PYRIMIDINO-4-CARBOXYLIC ESTERS, METHODS FOR THE PRODUCTION THEREOF, AND USE THEREOF AS HERBICIDES AND PLANT GROWTH REGULATORS [patent_app_type] => utility [patent_app_number] => 16/483672 [patent_app_country] => US [patent_app_date] => 2018-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16590 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16483672 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/483672
SUBSTITUTED BENZYL-4-AMINOPICOLINIC ESTERS AND PYRIMIDINO-4-CARBOXYLIC ESTERS, METHODS FOR THE PRODUCTION THEREOF, AND USE THEREOF AS HERBICIDES AND PLANT GROWTH REGULATORS Feb 5, 2018 Abandoned
Menu